Novavax Announces Reverse Stock Split of Common Stock
The reverse stock split affects all issued and outstanding shares of Novavax’ common stock. The par value of the Novavax’ common stock will remain unchanged at
No fractional shares will be issued in connection with the reverse split. Stockholders who would otherwise be entitled to receive a fractional share will instead receive a cash payment in lieu of such fractional shares equal to the fair market value of such fractional shares, as determined in good faith by Novavax’ Board of Directors.
Statements contained in this press release, including those relating to the sale of common stock, and those statements using words such as “expects” and “intends” are forward-looking statements that involve a number of risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. These risks and uncertainties include, but are not limited to: capital market risks; our ability to raise additional capital when needed; and other risk factors identified in Part I, Item 1A “Risk Factors,” of the Novavax Annual Report on Form 10-K for the year ended
Senior Manager, Investor & Public Relations
Source: Novavax, Inc.